These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 22120854

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome the study from Jiangsu, China of 5 years follow-up.
    Liu SJ, Guo ZR, Hu XS, Wu M, Chen FM, Kang GD, Zhou H, Guo L.
    Diabetes Res Clin Pract; 2008 Jul; 81(1):117-23. PubMed ID: 18485514
    [Abstract] [Full Text] [Related]

  • 3. High prevalence of abdominal obesity increases the risk of the metabolic syndrome in Nigerian type 2 diabetes patients: using the International Diabetes Federation worldwide definition.
    Ezenwaka CE, Okoye O, Esonwune C, Onuoha P, Dioka C, Osuji C, Oguejiofor C, Meludu S.
    Metab Syndr Relat Disord; 2014 Jun; 12(5):277-82. PubMed ID: 24601861
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Glucose intolerance (diabetes and IGT) in a selected South Indian population with special reference to family history, obesity and lifestyle factors--the Chennai Urban Population Study (CUPS 14).
    Mohan V, Shanthirani CS, Deepa R.
    J Assoc Physicians India; 2003 Aug; 51():771-7. PubMed ID: 14651136
    [Abstract] [Full Text] [Related]

  • 6. Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study.
    Bianchi C, Miccoli R, Bonadonna RC, Giorgino F, Frontoni S, Faloia E, Marchesini G, Dolci MA, Alviggi L, Gnasso A, Consoli A, Cavalot F, Cavallo MG, Leonetti F, Giaccari A, Del Prato S, GENFIEV Investigators.
    Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):699-705. PubMed ID: 21291660
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.
    Fontbonne A, Diouf I, Baccara-Dinet M, Eschwege E, Charles MA.
    Diabetes Metab; 2009 Nov; 35(5):385-91. PubMed ID: 19665415
    [Abstract] [Full Text] [Related]

  • 10. Impaired fasting glucose and impaired glucose tolerance do not predict hypertension: a community cohort study.
    Lee CJ, Lim NK, Kim HC, Ihm SH, Lee HY, Park HY, Park S.
    Am J Hypertens; 2015 Apr; 28(4):493-500. PubMed ID: 25267735
    [Abstract] [Full Text] [Related]

  • 11. People with impaired glucose tolerance and impaired fasting glucose are similarly susceptible to cardiovascular disease: a study in first-degree relatives of type 2 diabetic patients.
    Amini M, Horri N, Zare M, Haghighi S, Hosseini SM, Aminorroaya A, Hovsepian S.
    Ann Nutr Metab; 2010 Apr; 56(4):267-72. PubMed ID: 20413967
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of diabetes and impaired fasting glucose in a selected population with special reference to influence of family history and anthropometric measurements--the Kolkata policeman study.
    Kumar S, Mukherjee S, Mukhopadhyay P, Pandit K, Raychaudhuri M, Sengupta N, Ghosh S, Sarkar S, Mukherjee S, Chowdhury S.
    J Assoc Physicians India; 2008 Nov; 56():841-4. PubMed ID: 19263680
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prevalence of impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes in hemodialyzed patients when applying new diagnostic criteria.
    Elbert A, Schreier L, Galli C, Beresan H, Lopez G, Traversa M, Berg G.
    J Ren Nutr; 2006 Oct; 16(4):300-3. PubMed ID: 17046613
    [Abstract] [Full Text] [Related]

  • 17. Association of physical inactivity with components of metabolic syndrome and coronary artery disease--the Chennai Urban Population Study (CUPS no. 15).
    Mohan V, Gokulakrishnan K, Deepa R, Shanthirani CS, Datta M.
    Diabet Med; 2005 Sep; 22(9):1206-11. PubMed ID: 16108850
    [Abstract] [Full Text] [Related]

  • 18. Soluble P-selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome--the Chennai Urban Rural Epidemiology Study.
    Gokulakrishnan K, Deepa R, Mohan V, Gross MD.
    Metabolism; 2006 Feb; 55(2):237-42. PubMed ID: 16423632
    [Abstract] [Full Text] [Related]

  • 19. Very severely obese patients have a high prevalence of type 2 diabetes mellitus and cardiovascular disease.
    Vinciguerra F, Baratta R, Farina MG, Tita P, Padova G, Vigneri R, Frittitta L.
    Acta Diabetol; 2013 Jun; 50(3):443-9. PubMed ID: 23447004
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.